CLINICAL_TRIALS
trial_result
· 2026-01-12
Clinical Trial Update: Study of Ravulizumab in Pediatric Participants With HSCT-TMA [Phase 3]
Summary
A Phase 3 trial evaluating Ravulizumab in pediatric participants with hematopoietic stem cell transplantation-associated thrombotic microangiopathy has complete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Thrombotic Microangiopathy | Phase 3 | Status: COMPLETED | Results posted: 2026-01-12